Nov 23, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C,...
Nov 22, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy Capelini CM, da Silva TD, Tonks J, Watson S, Alvarez MPB, de Menezes LDC, Favero FM, Caromano FA, Massetti T, de Mello...
Nov 21, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study Fatehi F, Salort-Campana E, Le Troter A, Lareau-Trudel E, Bydder M, Fouré A, Guye M, Bendahan D, Attarian S PLoS One....
Nov 20, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Patients with Duchenne and Becker muscular dystrophies are not more asymmetrical than healthy controls on timed performance of upper limb tasks Artilheiro MC, Sá CSC, Fávero FM, Caromano FA, Voos MC. Braz J Med Biol Res. 2017. 50(8):...
Nov 19, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese Okama LO, Zampieri LM, Ramos CL, Toledo FO, Alves CRJ, Mattiello-Sverzut AC, Mayhew A, Sobreira CFR Neuromuscul Disord. 2017....
Nov 18, 2019 | Articles dans les revues scientifiques, Publications
< Retour aux Publications Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III Kölbel H, Hauffa BP, Wudy SA, Bouikidis A, Della Marina A, Schara U PLoS One. 2017. 9;12(3):e0173144. Etude de la prévalence de l’hyperleptinémie...
Recent Comments